Wasatch Advisors Inc Castle Biosciences Inc Transaction History

Wasatch Advisors Inc

  • $17.6 Billion
  • Q1 2025

A detailed history of Wasatch Advisors Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 998,455 shares of CSTL stock, worth $16.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
998,455
Previous 1,796,088 44.41%
Holding current value
$16.2 Million
Previous $47.9 Million 58.24%
% of portfolio
0.11%
Previous 0.24%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$18.76 - $32.72 $15 Million - $26.1 Million
-797,633 Reduced 44.41%
998,455 $20 Million
Q4 2024

Feb 13, 2025
SELL
$26.52 - $34.67 $795,706 - $1.04 Million
-30,004 Reduced 1.64%
1,796,088 $47.9 Million
Q3 2024

Nov 14, 2024
SELL
$17.4 - $31.47 $8.73 Million - $15.8 Million
-501,844 Reduced 21.56%
1,826,092 $52.1 Million
Q2 2024

Aug 14, 2024
SELL
$18.84 - $24.94 $4.2 Million - $5.57 Million
-223,152 Reduced 8.75%
2,327,936 $50.7 Million
Q1 2024

Apr 18, 2024
SELL
$18.06 - $25.3 $719,925 - $1.01 Million
-39,863 Reduced 1.54%
2,551,088 $56.5 Million
Q4 2023

Feb 14, 2024
SELL
$12.19 - $22.43 $2.31 Million - $4.26 Million
-189,793 Reduced 6.83%
2,590,951 $55.9 Million
Q3 2023

Nov 14, 2023
SELL
$13.28 - $20.3 $4.07 Million - $6.22 Million
-306,257 Reduced 9.92%
2,780,744 $47 Million
Q2 2023

Aug 07, 2023
BUY
$11.66 - $26.0 $1.25 Million - $2.78 Million
107,088 Added 3.59%
3,087,001 $42.4 Million
Q1 2023

May 12, 2023
SELL
$19.47 - $28.49 $4.72 Million - $6.91 Million
-242,649 Reduced 7.53%
2,979,913 $67.7 Million
Q4 2022

Feb 14, 2023
SELL
$18.08 - $30.0 $2.21 Million - $3.67 Million
-122,185 Reduced 3.65%
3,222,562 $75.9 Million
Q3 2022

Nov 14, 2022
SELL
$22.51 - $34.32 $8.12 Million - $12.4 Million
-360,771 Reduced 9.74%
3,344,747 $87.2 Million
Q2 2022

Aug 12, 2022
BUY
$16.0 - $45.99 $4.19 Million - $12 Million
261,671 Added 7.6%
3,705,518 $81.3 Million
Q1 2022

May 13, 2022
BUY
$33.17 - $46.98 $10.9 Million - $15.4 Million
327,359 Added 10.5%
3,443,847 $154 Million
Q4 2021

Feb 15, 2022
BUY
$39.06 - $67.58 $24.3 Million - $42.1 Million
622,786 Added 24.97%
3,116,488 $134 Million
Q3 2021

Nov 12, 2021
SELL
$60.13 - $77.6 $673,215 - $868,809
-11,196 Reduced 0.45%
2,493,702 $166 Million
Q2 2021

Aug 12, 2021
BUY
$50.07 - $76.78 $7.58 Million - $11.6 Million
151,419 Added 6.43%
2,504,898 $184 Million
Q1 2021

May 10, 2021
BUY
$58.92 - $97.33 $17 Million - $28.1 Million
288,648 Added 13.98%
2,353,479 $161 Million
Q4 2020

Feb 12, 2021
BUY
$43.6 - $73.05 $29.9 Million - $50.2 Million
686,774 Added 49.84%
2,064,831 $139 Million
Q3 2020

Nov 10, 2020
BUY
$38.47 - $52.03 $11 Million - $14.9 Million
286,275 Added 26.22%
1,378,057 $70.9 Million
Q2 2020

Aug 12, 2020
BUY
$27.28 - $43.01 $12 Million - $19 Million
441,637 Added 67.93%
1,091,782 $41.1 Million
Q1 2020

May 08, 2020
BUY
$23.08 - $35.53 $6.32 Million - $9.73 Million
273,778 Added 72.74%
650,145 $19.4 Million
Q4 2019

Feb 13, 2020
BUY
$15.74 - $35.04 $1.59 Million - $3.53 Million
100,856 Added 36.61%
376,367 $12.9 Million
Q3 2019

Nov 14, 2019
BUY
$18.09 - $27.92 $4.98 Million - $7.69 Million
275,511 New
275,511 $4.98 Million

Others Institutions Holding CSTL

# of Institutions
192
Shares Held
26.7M
Call Options Held
9.5K
Put Options Held
5K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $428M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email